RH Capital is an impact-first venture capital fund of Rhia Ventures that invests in early-stage startups revolutionizing women's health, with a focus on reproductive and maternal health equity in the United States. The firm is female-led and primarily backs women and BIPOC founders.
80% of their portfolio is in Healthcare. Their most common stage is series-a (60% of deals). Average disclosed round size is $13.2M (across 7 rounds with reported amounts).
Portfolio
10
Fund Size
$38.5M
Top Stage
Series A
Last 12 Mo
1
Team
EB
Elizabeth Bailey
Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nadia | Unknown | $12M | Mar 2026 |
 Twentyeight Health | Series A | — | Jan 2025 |
 Raydiant Oximetry | Series A | $7.5M | Jun 2024 |
 Evvy | Series A | — | Sep 2023 |
 Eli Health | Seed | — | Apr 2023 |
 Cayaba Care | Series A | $12M | Jun 2022 |
| TTestmate Health | Seed | $6M | — |
| AAOA | Seed | $17M | — |
 Novocuff | Series A | $26M | — |
 Bloomlife | Series A | $12.2M | — |
Top Co-Investors
Kapor Capital3 shared
SteelSky Ventures2 shared
SE Ventures2 shared
Labcorp2 shared
Amboy Street Ventures2 shared
The Helm2 shared
Charge Ventures1 shared
Muse Capital1 shared
Wellington Management1 shared
Citi Impact Fund1 shared
Digitalis Ventures1 shared
Flare Capital Partners1 shared
Stanford's StartX Fund1 shared
Impact Engine1 shared
Third Prime1 shared
Impact America Fund1 shared
Gratitude Railroad1 shared
Left Lane Capital1 shared
Virtue1 shared
G9 Ventures1 shared
Last updated: 20 October 2026